Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CytomX Therapeutics (CTMX) Return on Assets (2016 - 2025)

Historic Return on Assets for CytomX Therapeutics (CTMX) over the last 11 years, with Q3 2025 value amounting to 0.17%.

  • CytomX Therapeutics' Return on Assets rose 800.0% to 0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.2% for FY2024, which is 2000.0% up from last year.
  • CytomX Therapeutics' Return on Assets amounted to 0.17% in Q3 2025, which was up 800.0% from 0.35% recorded in Q2 2025.
  • In the past 5 years, CytomX Therapeutics' Return on Assets registered a high of 0.38% during Q1 2025, and its lowest value of 0.52% during Q3 2022.
  • Its 5-year average for Return on Assets is 0.1%, with a median of 0.19% in 2023.
  • In the last 5 years, CytomX Therapeutics' Return on Assets crashed by -2400bps in 2022 and then surged by 4700bps in 2023.
  • Quarter analysis of 5 years shows CytomX Therapeutics' Return on Assets stood at 0.33% in 2021, then fell by -25bps to 0.41% in 2022, then surged by 99bps to 0.0% in 2023, then skyrocketed by 9228bps to 0.25% in 2024, then plummeted by -32bps to 0.17% in 2025.
  • Its last three reported values are 0.17% in Q3 2025, 0.35% for Q2 2025, and 0.38% during Q1 2025.